These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33466673)

  • 1. A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.
    Thompson EM; Stoker AW
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution crystal structure of the catalytic domain of human dual-specificity phosphatase 26.
    Won EY; Xie Y; Takemoto C; Chen L; Liu ZJ; Wang BC; Lee D; Woo EJ; Park SG; Shirouzu M; Yokoyama S; Kim SJ; Chi SW
    Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):1160-70. PubMed ID: 23695260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic structure of dual-specificity phosphatase 26, a novel p53 phosphatase.
    Lokareddy RK; Bhardwaj A; Cingolani G
    Biochemistry; 2013 Feb; 52(5):938-48. PubMed ID: 23298255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs.
    Patterson KI; Brummer T; Daly RJ; O'Brien PM
    Biochim Biophys Acta; 2010 Sep; 1803(9):1003-12. PubMed ID: 20347885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
    Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
    Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Insight into the Critical Role of the N-Terminal Region in the Catalytic Activity of Dual-Specificity Phosphatase 26.
    Won EY; Lee SO; Lee DH; Lee D; Bae KH; Lee SC; Kim SJ; Chi SW
    PLoS One; 2016; 11(9):e0162115. PubMed ID: 27583453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma.
    Shang X; Vasudevan SA; Yu Y; Ge N; Ludwig AD; Wesson CL; Wang K; Burlingame SM; Zhao YJ; Rao PH; Lu X; Russell HV; Okcu MF; Hicks MJ; Shohet JM; Donehower LA; Nuchtern JG; Yang J
    Oncogene; 2010 Sep; 29(35):4938-46. PubMed ID: 20562916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphotyrosine Substrate Sequence Motifs for Dual Specificity Phosphatases.
    Zhao BM; Keasey SL; Tropea JE; Lountos GT; Dyas BK; Cherry S; Raran-Kurussi S; Waugh DS; Ulrich RG
    PLoS One; 2015; 10(8):e0134984. PubMed ID: 26302245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-specificity phosphatases: critical regulators with diverse cellular targets.
    Patterson KI; Brummer T; O'Brien PM; Daly RJ
    Biochem J; 2009 Mar; 418(3):475-89. PubMed ID: 19228121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-specificity phosphatase 26 protects against kidney injury caused by ischaemia-reperfusion through restraint of TAK1-JNK/p38-mediated apoptosis and inflammation of renal tubular epithelial cells.
    Xiang H; Li Z; Li Y; Zheng J; Dou M; Xue W; Wu X
    Toxicol Appl Pharmacol; 2024 Jun; 487():116954. PubMed ID: 38705402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
    Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y
    Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion.
    Tanuma N; Nomura M; Ikeda M; Kasugai I; Tsubaki Y; Takagaki K; Kawamura T; Yamashita Y; Sato I; Sato M; Katakura R; Kikuchi K; Shima H
    Oncogene; 2009 Feb; 28(5):752-61. PubMed ID: 19043453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
    Huang F; Sheng XX; Zhang HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overproduction, purification and structure determination of human dual-specificity phosphatase 14.
    Lountos GT; Tropea JE; Cherry S; Waugh DS
    Acta Crystallogr D Biol Crystallogr; 2009 Oct; 65(Pt 10):1013-20. PubMed ID: 19770498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth.
    Kim H; Lee HJ; Oh Y; Choi SG; Hong SH; Kim HJ; Lee SY; Choi JW; Su Hwang D; Kim KS; Kim HJ; Zhang J; Youn HJ; Noh DY; Jung YK
    Nat Commun; 2014; 5():3351. PubMed ID: 24548998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor.
    Seo H; Cho S
    Pharmazie; 2016 Apr; 71(4):196-200. PubMed ID: 27209699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.
    Ye P; Liu J; Xu W; Liu D; Ding X; Le S; Zhang H; Chen S; Chen M; Xia J
    Hepatology; 2019 May; 69(5):1946-1964. PubMed ID: 30582764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DUSP9, a Dual-Specificity Phosphatase with a Key Role in Cell Biology and Human Diseases.
    Khoubai FZ; Grosset CF
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1.
    Zhao J; Jiang X; Liu J; Ye P; Jiang L; Chen M; Xia J
    J Am Heart Assoc; 2021 Feb; 10(4):e014311. PubMed ID: 33522247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-specificity MAP kinase phosphatases as targets of cancer treatment.
    Nunes-Xavier C; Romá-Mateo C; Ríos P; Tárrega C; Cejudo-Marín R; Tabernero L; Pulido R
    Anticancer Agents Med Chem; 2011 Jan; 11(1):109-32. PubMed ID: 21288197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.